ALLARITY ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Allarity Therapeutics, Inc. and Encourages Investors to Contact the FirmGlobeNewsWire • 09/18/24
Stockholders With Losses In Allarity Therapeutics, Inc. Are Urged To Help The Schall Law Firm With A Lawsuit For Securities Law ViolationsAccesswire • 09/17/24
Rosen Law Firm Urges Allarity Therapeutics, Inc. (NASDAQ: ALLR) Stockholders with Large Losses to Contact the Firm for Information About Their RightsBusiness Wire • 09/17/24
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Allarity Therapeutics, Inc. (ALLR) InvestorsBusiness Wire • 09/17/24
Allarity Therapeutics Inc May Have Defrauded The Public And The Schall Law Firm Seeks Shareholder Participation In A CaseAccesswire • 09/17/24
Investor Notice: Robbins LLP Informs Stockholders of the Class Action Lawsuit Filed Against Allarity Therapeutics, Inc.GlobeNewsWire • 09/16/24
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Allarity Therapeutics, Inc. (ALLR) InvestorsBusiness Wire • 09/16/24
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Allarity Therapeutics, Inc. (ALLR)GlobeNewsWire • 09/16/24
SHAREHOLDER ALERT: Class Action Lawsuit Filed on Behalf of Allarity Therapeutics, Inc. (ALLR) Investors – Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact the FirmGlobeNewsWire • 09/16/24
Pomerantz Law Firm Announces the Filing of a Class Action Against Allarity Therapeutics, Inc. and Certain Officers - ALLRAccesswire • 09/13/24
Allarity Therapeutics Announces New CFO and Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewsWire • 09/13/24
Allarity Therapeutics Takes Decisive Step Toward Regaining Nasdaq Compliance with Nasdaq Listing Rule 5550(a)(2)GlobeNewsWire • 09/11/24
Wolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating Allarity Therapeutics, Inc. (NASDAQ: ALLR) for potential violations of federal securities lawsPRNewsWire • 08/23/24
Wolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating Allarity Therapeutics, Inc. for potential violations of federal securities lawsAccesswire • 08/22/24
ALLARITY THERAPEUTICS, INC. ANNOUNCEMENT: If You Have Suffered Losses in Allarity Therapeutics, Inc. (NASDAQ: ALLR), You Are to Contact The Rosen Law Firm About Your RightsGlobeNewsWire • 08/20/24
Rosen Law Firm Encourages Allarity Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation - ALLRPRNewsWire • 08/20/24
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Allarity Therapeutics, Inc. - ALLRAccesswire • 08/19/24
Allarity Therapeutics Is Being Investigated By The Schall Law Firm For Securities Law Violations And Encourages Shareholders To JoinAccesswire • 08/19/24
Wolf Haldenstein Adler Freeman & Herz LLP Announces that it is Investigating Allarity Therapeutics, Inc. (NASDAQ: ALLR) for Potential Violations of Federal Securities LawsAccesswire • 08/19/24
The Schall Law Firm Is Investigating Allarity Therapeutics For Securities Fraud And Invites Investors To JoinAccesswire • 08/18/24
The Schall Law Firm Is Looking Into Allarity Therapeutics For Securities Fraud And Encourages Shareholders To JoinAccesswire • 08/17/24
The Schall Law Firm's Allarity Therapeutics Inc Securities Fraud Investigation Is Open For ALLR InvestorsAccesswire • 08/15/24
The Schall Law Firm's Allarity Therapeutics Inc Securities Fraud Investigation Is Available For ALLR InvestorsAccesswire • 08/14/24
Allarity Therapeutics Inc Securities Fraud Investigation By The Schall Law Firm Is Open For ALLR InvestorsAccesswire • 08/14/24
The Schall Law Firm Opens Securities Fraud Investigation Into Allarity Therapeutics Inc For ALLR InvestorsAccesswire • 08/13/24
